As populations age worldwide, the burden of valvular heart disease has grown
exponentially, and so has the proportion of affected women. Although rheumatic valve …

Growing clinical data support the use of transcatheter therapies for significant mitral valve
disease. Currently, edge-to-edge repair is the transcatheter treatment of choice, but many …

Abstract The 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart
Failure Treatment was created to provide a practical, streamlined resource for clinicians …

Secondary (or functional) mitral regurgitation (SMR) occurs frequently in chronic heart failure
(HF) with reduced left ventricular (LV) ejection fraction, resulting from LV remodelling that …

Background The presence of tricuspid regurgitation (TR) may affect prognosis in patients
with mitral regurgitation (MR). Objectives This study sought to determine the impact of TR on …

Key Clinical Points Secondary Mitral Regurgitation Mitral regurgitation can be broadly
classified into two different categories—primary and secondary mitral regurgitation. The …

There has been rapid progress in transcatheter therapies for mitral regurgitation. These
developments have elevated the need for the imager to have a core understanding of the …

Background Discrepancies have been observed between transthoracic echocardiography
(TTE) and cardiac magnetic resonance imaging (CMR) severity grading in primary mitral …

Background Anatomical and clinical criteria to define mitral transcatheter edge-to-edge
repair (TEER)“unsuitability” have been proposed on the basis of a Heart Valve Collaboratory …

Rebecca T. Hahn, MD, FASE (Chair), Muhamed Saric, MD, PhD, FASE (Co-Chair),
Francesco Fulvio Faletra, MD, Ruchira Garg, MD, FASE, Linda D. Gillam, MD, MPH, FASE …